share_log

藥明巨諾-B：2024年6月18日舉行之股東週年大會之代表委任表格

JW THERAP-B: Form of proxy for the Annual General Meeting to be held on June 18, 2024

Hong Kong Stock Exchange ·  Apr 25 18:58
Summary by Moomoo AI
藥明巨諾-B（股份代號：2126）將於2024年6月18日上午十時在中國上海浦東新區中科路699號B棟5層展示廳會議室舉行股東週年大會。會議將審議包括接收及採納截至2023年12月31日止年度經審核綜合財務報表、董事會報告及核數師報告在內的多項決議案。此外，會上將進行董事選舉，包括執行董事李怡平醫生、非執行董事Sungwon Song博士、獨立非執行董事Krishnan Viswanadhan博士及Ann Li Lee博士的重選。會議還將授權董事會釐定董事薪酬，續聘羅兵咸永道會計師事務所為核數師，並授權董事發行不超過已發行股份總數20%的額外股份及購回不超過10%的股份。另外，將審議批准採納公司第九次經修訂及重述的組織章程大綱及細則。股東可委任代表出席大會並投票，並需於會議前至少48小時提交代表委任表格。
藥明巨諾-B（股份代號：2126）將於2024年6月18日上午十時在中國上海浦東新區中科路699號B棟5層展示廳會議室舉行股東週年大會。會議將審議包括接收及採納截至2023年12月31日止年度經審核綜合財務報表、董事會報告及核數師報告在內的多項決議案。此外，會上將進行董事選舉，包括執行董事李怡平醫生、非執行董事Sungwon Song博士、獨立非執行董事Krishnan Viswanadhan博士及Ann Li Lee博士的重選。會議還將授權董事會釐定董事薪酬，續聘羅兵咸永道會計師事務所為核數師，並授權董事發行不超過已發行股份總數20%的額外股份及購回不超過10%的股份。另外，將審議批准採納公司第九次經修訂及重述的組織章程大綱及細則。股東可委任代表出席大會並投票，並需於會議前至少48小時提交代表委任表格。
The Annual General Meeting will be held on 18 June 2024 at 10:00am in the 5th Floor Exhibition Hall B, Building 699 Zhongko Road, Pudong New District, Shanghai, China, at 10:00am. The Meeting will consider a number of resolutions including the receipt and adoption of the Audited Consolidated Financial Statements, the Board's Report and the Auditor's Report for the year ended 31 December 2023. In addition, a director election will be held at the meeting, including the re-election of Dr. Lee Yi-ping, Dr. Sungwon Song, Non-Executive Director Dr. Krishnan Viswanadhan, and Dr. Ann Li Lee, Independent Non-Executive Director. The meeting will also authorize the Board of Directors to determine the remuneration of directors, to renew the duties of the Board of Accountants...Show More
The Annual General Meeting will be held on 18 June 2024 at 10:00am in the 5th Floor Exhibition Hall B, Building 699 Zhongko Road, Pudong New District, Shanghai, China, at 10:00am. The Meeting will consider a number of resolutions including the receipt and adoption of the Audited Consolidated Financial Statements, the Board's Report and the Auditor's Report for the year ended 31 December 2023. In addition, a director election will be held at the meeting, including the re-election of Dr. Lee Yi-ping, Dr. Sungwon Song, Non-Executive Director Dr. Krishnan Viswanadhan, and Dr. Ann Li Lee, Independent Non-Executive Director. The meeting will also authorize the Board of Directors to determine the remuneration of directors, to renew the duties of the Board of Accountants of Hong Kong, and to authorize the directors to issue additional shares not exceeding 20% of the total issued shares and to repurchase not more than 10% of the shares. In addition, the Company's 9th revised and revised Articles of Association will be approved for the adoption of the Company's Articles of Association and Conditions. Shareholders may appoint representatives to attend and vote at the General Meeting and the Proxy Form must be submitted at least 48 hours prior to the meeting.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more